Kadmon Holdings, Inc.

Ownership Transactions Reported by 11 Insiders

Industry
Pharmaceutical Preparations
Location
450 East 29 Th Street, New York, NY

There are no Buy or Sell transactions made by insiders since 10/5/2023

Kadmon Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Harlan Waksal President, CEO, Director Nov 9, 2021
David E. Cohen Director Nov 9, 2021
Cynthia Louise Flowers Director Nov 8, 2021
Kyle Carver SVP, CAO, Controller Nov 9, 2021
Steven Meehan EVP, Chief Financial Officer Nov 9, 2021
Gregory S. Moss EVP, Gen. Coun. / CCO. Nov 9, 2021
John Ryan EVP, Chief Medical Officer Nov 9, 2021
Eugene Bauer Director Nov 9, 2021
Arthur S. Kirsch Director Nov 9, 2021
Tasos Konidaris Director Nov 9, 2021
Nancy Miller-Rich Director Nov 9, 2021

Recent Insider Transactions by Companies or Individuals for Kadmon Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.